A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)

Name: A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
Published: 2024
License: Public Domain

Nkarta, Inc. · 2024

ClinicalTrials.gov · Datasets · License: Public Domain · 2024

Open Source ↗

car cell-therapy immunotherapy

lupus nephritis, primary membranous nephropathy, cd19, car, allogeneic, nkx019, interleukin 15, cell therapy, immunotherapy, adoptive cell therapy, ntrust-1, ln

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 900864
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.